Anyplex™Ⅱ HPV HR Detection simultaneously detects, differentiates and quantifies 14 high-risk HPV genotypes including HPV16 and HPV18 which are implicated as major risk factors for cervical cancer. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instrument and enables accurate screening test of HPV infection in a single reaction.

Detection of 14 high-risk HPV genotypes in a single reaction

Useful tool for surveillance and infection control

Automated data interpretation and LIS interlocking with Seegene Viewer

Utilization of the UDG system to prevent carry-over contamination

Quantitative analysis by cyclic-CMTA

Convenient workflow using Seegene’s automated one platform

Whole process validation from extraction to PCR by whole process control

Assistant of appropriate treatment and management for co-infection

Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies
The result represents co-infection that HPV 16 is low (+) in the HEX channel, HPV 18 is intermediate (++) in the Quasar 670 channel.